Abbott Laboratories
NYSE:ABT
Wall Street
Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABT
is 129.28 USD
with a low forecast of 108.07 USD and a high forecast of 148.05 USD.
ABT Last Price Targets
Abbott Laboratories
The latest public price target was made on Apr 22, 2024 by
Matt Miksic
from
Barclays
,
who expects
ABT
stock to
rise by 30%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Matt Miksic
Barclays
|
140
USD
Upside 30% |
6 days ago
Apr 22, 2024
|
Abbott Labs (ABT) PT Lowered to $140 at Barclays
StreetInsider
|
Shagun Singh
RBC Capital
|
125
USD
Upside 16% |
1 week ago
Apr 18, 2024
|
Abbott Labs (ABT) PT Lowered to $125 at RBC Capital
StreetInsider
|
Lee Hambright
Bernstein
|
133
USD
Upside 24% |
1 week ago
Apr 18, 2024
|
Abbott Q1 strong but still in penalty box on litigation overhang, says Bernstein
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABT's stock price target?
Price Target
129.28
USD
According to Wall Street analysts, the average 1-year price target for
ABT
is 129.28 USD
with a low forecast of 108.07 USD and a high forecast of 148.05 USD.
What is Abbott Laboratories's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Abbott Laboratories's revenue is
9%.
The projected
CAGR
for the next 3 years is
7%.
What is Abbott Laboratories's Operating Income forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
Abbott Laboratories's operating income is
11%.
The projected
CAGR
for the next 3 years is
20%.
What is Abbott Laboratories's Net Income forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
Abbott Laboratories's net income is
3%.
The projected
CAGR
for the next 3 years is
20%.
You don't have any saved screeners yet
